nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Access to medicines in low-income countries
|
Marthe Everard |
|
2003 |
15 |
1-2 |
p. 137-149 |
artikel |
2 |
Data needed for developing and monitoring policies
|
Elias Mossialos |
|
2003 |
15 |
1-2 |
p. 15-27 |
artikel |
3 |
Drugs and Money
|
|
|
2003 |
15 |
1-2 |
p. 1-3 |
artikel |
4 |
Experiences with budgets
|
Christine Huttin |
|
2003 |
15 |
1-2 |
p. 81-84 |
artikel |
5 |
Experiences with generics
|
Kees de Joncheere |
|
2003 |
15 |
1-2 |
p. 101-109 |
artikel |
6 |
Experiences with patient charges
|
Flora M. Haaijer-Ruskamp |
|
2003 |
15 |
1-2 |
p. 93-96 |
artikel |
7 |
Experiences with pharmacy benefit management programmes in the USA
|
Helene L. Lipton |
|
2003 |
15 |
1-2 |
p. 111-118 |
artikel |
8 |
Experiences with professional education
|
Stephen Chapman |
|
2003 |
15 |
1-2 |
p. 119-125 |
artikel |
9 |
Experiences with reference pricing
|
Christine Huttin |
|
2003 |
15 |
1-2 |
p. 85-91 |
artikel |
10 |
Making use of economic evaluation
|
David McDaid |
|
2003 |
15 |
1-2 |
p. 67-74 |
artikel |
11 |
Measures relating to use of drug subsidy lists and to regulation
|
A.S. Mitchell |
|
2003 |
15 |
1-2 |
p. 77-79 |
artikel |
12 |
Methods for monitoring and evaluating processes and outcomes
|
Monique F. Mrazek |
|
2003 |
15 |
1-2 |
p. 55-66 |
artikel |
13 |
Policy options for cost containment of pharmaceuticals
|
Ad H. Rietveld |
|
2003 |
15 |
1-2 |
p. 29-54 |
artikel |
14 |
Providing affordable medicines in transitional countries
|
Kees de Joncheere |
|
2003 |
15 |
1-2 |
p. 127-135 |
artikel |
15 |
Scope of the problem
|
Kees de Joncheere |
|
2003 |
15 |
1-2 |
p. 7-13 |
artikel |
16 |
Switching to non-prescription status
|
Peter R. Noyce |
|
2003 |
15 |
1-2 |
p. 97-99 |
artikel |